• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Infect Dis Ther . Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study

tetano

Editor, Senior Moderator
Infect Dis Ther


. 2023 May 17.
doi: 10.1007/s40121-023-00813-1. Online ahead of print. Dynamic NLR and PLR in Predicting COVID-19 Severity: A Retrospective Cohort Study

Erika Asperges[SUP] #[/SUP][SUP] 1 [/SUP], Giuseppe Albi[SUP] #[/SUP][SUP] 2 [/SUP], Valentina Zuccaro[SUP] 1 [/SUP], Margherita Sambo[SUP] 1 3 [/SUP], Teresa C Pieri[SUP] 1 3 [/SUP], Matteo Calia[SUP] 1 3 [/SUP], Marta Colaneri[SUP] 1 [/SUP], Laura Maiocchi[SUP] 1 [/SUP], Federica Melazzini[SUP] 4 [/SUP], Angioletta Lasagna[SUP] 5 [/SUP], Andrea Peri[SUP] 6 [/SUP], Francesco Mojoli[SUP] 7 [/SUP], Paolo Sacchi[SUP] 1 [/SUP], Raffaele Bruno[SUP] 8 9 [/SUP]



Affiliations
Abstract

Introduction: The hyperinflammation phase of severe SARS-CoV-2 is characterised by complete blood count alterations. In this context, the neutrophil-to-lymphocyte ratio (NLR) and the platelet-to-lymphocyte ratio (PLR) can be used as prognostic factors. We studied NLR and PLR trends at different timepoints and computed optimal cutoffs to predict four outcomes: use of continuous positive airways pressure (CPAP), intensive care unit (ICU) admission, invasive ventilation and death.
Methods: We retrospectively included all adult patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia admitted from 23 January 2020 to 18 May 2021. Analyses included non-parametric tests to study the ability of NLR and PLR to distinguish the patients' outcomes at each timepoint. Receiver operating characteristic (ROC) curves were built for NLR and PLR at each timepoint (minus discharge) to identify cutoffs to distinguish severe and non-severe disease. Their statistical significance was assessed with the chi-square test. Collection of data under the SMACORE database was approved with protocol number 20200046877.
Results: We included 2169 patients. NLR and PLR were higher in severe coronavirus disease 2019 (COVID-19). Both ratios were able to distinguish the outcomes at each timepoint. For NLR, the areas under the receiver operating characteristic curve (AUROC) ranged between 0.59 and 0.81, and for PLR between 0.53 and 0.67. From each ROC curve we computed an optimal cutoff value.
Conclusion: NLR and PLR cutoffs are able to distinguish severity grades and mortality at different timepoints during the course of disease, and, as such, they allow a tailored approach. Future prospects include validating our cutoffs in a prospective cohort and comparing their performance against other COVID-19 scores.

Keywords: COVID-19; Cutoff; ICU; Mortality; NLR; PLR.

 
Back
Top Bottom